In contrast, treatment with Ad-p53 monotherapy resulted in significantly decreased tumor growth and Ad-p53 + anti-PD-1 combination therapy reversed anti-PD-1 treatment resistance (see Fig. 1). The gene discussed is TP53; the disease is neoplasm.